Past event: RNA Therapeutics USA Conference

Bolstering The Latest Advances and Opportunities in RNA-Based Medicine

We are proud to announce the inaugural RNA Therapeutics USA Conference taking place in San Diego on the 14 - 15th June 2023.

As part of our leading portfolio of Drug Discovery and the long-standing RNA Therapeutics Europe conferences, we are delighted to introduce RNA Therapeutics USA.

RNA therapies are leading the way in the field of genetic medicine, with the market expected to reach 1.81 billion USD by 2025, growing at a CAGR of 7.5%. This in large can be attributed to the topical advancements in mRNA vaccines, paving the way for global regulatory successes.

We currently see the RNA Therapeutic field focus on the challenges associated with delivery of RNA molecules extrahepatically, with a particular drive to overcome barriers of delivery to the Central Nervous System. In addition, RNA technologies continue to lead the way in revolutionising immunotherapies and the vaccine landscape, along with exceptional potential to treat a wide variety of chronic, previously undruggable diseases. The 2023 agenda will address these latest challenges along with recent advancements in RNAi and continue to drive innovation in the field of RNA Therapeutics.

Don't miss this opportunity to network with the pharma and biotech community of global experts in the UK and Europe; the two-day agenda offers you peer-to-peer networking with Directors of novel RNA therapies, CEOs, Senior and expert scientists, Chief Medical Officers, Senior Vice Presidents and many more.

Benefits of Attending

  • Learn how RNA Therapies are revolutionising treatment for chronic diseases of the liver, heart, CNS and musculoskeletal system.
  • Investigate the latest trends in RNA immunotherapies as a tool for designing novel RNA based vaccines
  • Enhance your knowledge of the latest innovations in RNA application and RNA delivery techniques with case studies from leading industry experts
  • Engage in the growing advances and development of novel RNAi technologies in the treatment of chronic diseases

Who should attend

Key Job Titles include:
  • Research & Development Directors/Managers/Scientists
  • Heads of Clinical Development
  • Heads of Pre-Clinical Development
  • Head of RNA Biology
  • Head of RNA Formulation and Drug Delivery
  • Head of Pre-clinical R&D
  • Head of New Modalities
  • Head of Discovery
  • Senior Scientists
  • Chief Scientific Officers
  • Chief Medical Officers
Global Presence:
Attendees from all over the world attend our events, gain hands on insight from representatives from UK, Europe and USA.

Featured Speakers

  • Aditya Venkatesh, Senior Principal Scientist, Stoke Therapeutics Inc
  • Alfica Sehgal, SVP Head of Discovery & Translation, CAMP4 Therapeutics
  • Archit Rastogi, Assistant Director, Preclinical Development , Ionis Pharmaceuticals Inc.
  • Chuong Huynh, Biologist Officially / Vaccine Product Coordination Team Lead Unofficially, Biomedical Advanced Research & Development Authority (BARDA)
  • Heinrich Haas, Former Vice President Formulation & Drug Delivery, BioNTech
  • Ho-Chou Tu, Associate Director, Alnylam Pharmaceuticals
  • Jay Sarkar, Researcher and Entrepreneur, Stanford University
  • Jimmy Weterings, Senior Director, Technology Innovation, Sirnaomics, Inc
  • Martin Akerman, CTO & Co-Founder, Envisagenics
  • Michelle Lynn-Hall, Associate Vice President, Genetic Nanomedicine, Eli Lilly
  • Ramana Doppalapudi, Vice President Chemistry, Avidity Biosciences Inc.
  • Rushit N Lodaya, Expert Scientist, GSK
  • Samir Ounzain, CEO, HAYA Therapeutics
  • Stefano Zanotti, Senior Director, Head of Neuromuscular Research, Dyne Therapeutics
  • Steven Reed, CEO, HDT Bio
  • Tamar Grossman, Vice President, Global Head of RNA and Targeted Therapeutics, Janssen Pharmaceutical Companies of Johnson & Johnson
  • Ying Yu, Associate Director, AbbVie

Please fill in your name and email to receive the Conference Agenda of this event.

Venue

Horton Grand Hotel
311 Island Ave, 92101
San Diego, CA, USA


To access our preferential rate please contact gwendolyn@hortongrand.com or (619) 374-6018, stating that you are part of the SMi room block.

Our preferential rate is $218 per night*
Rate expires on Saturday, May 20th 2023.
Breakfast not included. 48 hour cancellation policy.
*Saturday June 10th priced at $248 per night. Rates are before tax.
Kindly note: Rates and rooms are subject to availability and cannot be guaranteed

Alternative hotels in the area:
Alternatively you can use, booking.com which is a helpful site when exploring all your options
Event details
Organizer : SAE Media Group
Event type : Conference
Reference : ASDE-24224